洛拉提尼布相关的体重增加和脂质不良症:回顾性分析和对未来护理的影响
A John1, D J McMahon1, D Chauhan1
1The Lung Unit, The Royal Marsden NHS Trust, UK.
Lung cancer (Amsterdam, Netherlands)
|November 20, 2024
概括
洛拉提尼布经常导致ALK/ROS1阳性NSCLC患者的体重增加和脂质失调. 管理策略对于维持生活质量和预防进一步的健康问题至关重要.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床毒理学 临床毒理学
背景情况:
- 洛拉提尼布是治疗形淋巴瘤激酶 (ALK) 和ROS1阳性非小细胞肺癌 (NSCLC) 的有效治疗方法.
- 了解与治疗相关的毒性,如体重增加和脂质不良症,对于长期的患者管理至关重要.
研究的目的:
- 为了对洛拉提尼布相关的体重增加和脂质不良症的现实发病率和严重程度进行基准测试.
- 为未来的治疗策略提供信息,以减轻这些洛拉提尼布毒性.
主要方法:
- 对43名ALK/ROS1阳性NSCLC患者的回顾性观察分析,这些患者在英国接受了洛拉提尼布治疗.
- 使用CTCAE v5.0分级评估体重,BMI,甘油三和胆固醇的变化.
- 排除没有记录基线体重的患者.
主要成果:
- 81%的患者体重增加 (中位数为4.5公斤,增加6.5%);79%的BMI增加.
- 91%的人患有增加的总胆固醇,68%的人患有增加的甘油三.
- 86%需要降脂疗法; 一名患者心肌梗塞.
结论:
- 体重增加和脂质失调是洛拉提尼布常见的毒性,需要主动管理.
- 观察到的比率与CROWN试验相似,强调有毒性减轻的必要性.
- 管理这些副作用对于维持患者的生活质量和预防NSCLC患者的发病率至关重要,结果有利.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
536
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
536
Oral Hypoglycemic Agents: Biguanides and Glitazones
174
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
174
Overview of Lipid Metabolism
1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Insulin: Dosing Regimen and Adverse Effects
145
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
145
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Drugs for Treatment of Constipation-Predominant IBS
134
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
134


